HMGN1 and melanoma: This was accompanied by a reduction of HMGB1 and HMGN1 in melanoma cell lysates (Figures 2I, J), indicating that LTX-315 treatment results in the translocation/release of both these DAMPs/alarmins from A375 and B16F10 cells into the supernatant.